Drawing for EMERGEN-C IMMUNE DEFENSE

USPTO serial 78853629

EMERGEN-C IMMUNE DEFENSE

Reviewed by CopyMark Law Group

Reg. 3306845Status 710
Filing date
Status date
Registration date
Oct 9, 2007
Examiner
CHENG, CHI TANG P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EMERGEN-C IMMUNE DEFENSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard A. Friedman

Richard A. Friedman Pfizer Inc.235 East 42nd StreetNew York, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Flavored vitamin drink mixes and flavored vitamin lozengesSECTION 8 - CANCELLEDMar 31, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2014C8..CANCELLED SEC. 8 (6-YR)—
Nov 21, 2012NOSUNOTICE OF SUIT—
Jul 20, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 20, 2011NOSUNOTICE OF SUIT—
Jun 16, 2008NOSUNOTICE OF SUIT—
Oct 9, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2007ISIRWITHDRAWN FROM ISSUE - TQR/NON-ATTY REQUEST—
Jul 3, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2007NPUBNOTICE OF PUBLICATION—
Apr 28, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 19, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 13, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2007ALIEASSIGNED TO LIE—
Mar 12, 2007MAILPAPER RECEIVED—
Sep 21, 2006GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 21, 2006CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 15, 2006DOCKASSIGNED TO EXAMINER—
Apr 8, 2006MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 7, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance